APPLICATION
ANDA075747
TYPE
ANDA
ORIGINAL APPROVAL
2004-06-09
LATEST ACTION
2013-11-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CIPROFLOXACIN HYDROCHLORIDEDiscontinued
CIPROFLOXACIN HYDROCHLORIDE EQ 500MG BASE · TABLET · ORAL
CIPROFLOXACIN HYDROCHLORIDEDiscontinued
CIPROFLOXACIN HYDROCHLORIDE EQ 750MG BASE · TABLET · ORAL
CIPROFLOXACIN HYDROCHLORIDEDiscontinued
CIPROFLOXACIN HYDROCHLORIDE EQ 250MG BASE · TABLET · ORAL
Approval history
2013-11-18Labeling · Supplement 12AP
2013-11-18Labeling · Supplement 15 · standardAP
2013-11-18Labeling · Supplement 13AP
2013-11-18Labeling · Supplement 14 · standardAP
2009-07-22Labeling · Supplement 11AP
2008-12-04Labeling · Supplement 10AP
2008-06-18Labeling · Supplement 9AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.